Premium
Early central line‐associated blood stream infections in children with cancer pose a risk for premature catheter removal
Author(s) -
Moell Jacob,
Svenningsson Anna,
Af Sandeberg Margareta,
Larsson Magnus,
Heyman Mats,
HarilaSaari Arja,
Nilsson Anna
Publication year - 2019
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/apa.14432
Subject(s) - medicine , blood stream , central venous catheter , incidence (geometry) , central line , catheter , malignancy , bacteremia , pediatrics , cancer , retrospective cohort study , blood culture , surgery , antibiotics , physics , microbiology and biotechnology , optics , biology
Aim This study examined the clinical characteristics of central line‐associated blood stream infections occurring within 30 days after insertion versus later infections in paediatric cancer patients and the subsequent risk for premature catheter removal. Methods This was a retrospective study of children aged 0–18 years who were diagnosed with cancer from 2013 to 2014 at the Astrid Lindgren Children Hospital, Sweden. Clinical and microbiology data for each patient were collected for 365 days after the central venous catheter (CVC) was inserted. Results During the study period, 154 children received a CVC. The overall incidence of central line associated blood stream infections was 2.0 per 1000 catheter days. A total of 108 infectious episodes were identified in 44/154 (29%) patients. Of those, 15/44 children (29%) had an early infection within 30 days and alpha‐haemolytic Streptococci and coagulase‐negative Staphylococci dominated. Children with early infections were more likely to have a haematological malignancy and to need premature removal of the CVC due to repeated infections. Conclusion We observed a high prevalence of early CVC associated blood stream infection mainly in patients with haematological malignancies. Our study highlights the importance of preventive measures in reducing infections in paediatric cancer patients.